ADMA Biologics Inc vs Bilibili Inc — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Bilibili Inc trades at $17.77 (market cap $7.65B). The key difference: Bilibili Inc is far larger — about 3.4× ADMA Biologics Inc's market cap. Which is the better fit depends on your goals.
| ADMA | BILI | |
|---|---|---|
Market Cap | $2.22B | $7.65B |
Sector | Health | Media |
52-Week High | $20.38 | $35.92 |
52-Week Low | $7.60 | $15.96 |
Enterprise Value | $2.29B | $5.49B |
Trailing returns across standard periods
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Bilibili is a leading video sharing and online entertainment platform for Gen Z in China. It offers a diverse range of content, including anime, games, and live broadcasting, fueled by a highly engaged community.
Read more on BILI →